Cancer cells isolated from malignant pleural and peritoneal effusions inhibit phospholipase A2 activity in human polymorphonuclear leukocytes

Cancer Letters

Volumn 121, Issue 2, 1997, Pages 155-161

  Abe, Masayoshi ^a   Kitsuki, Hisao ^b   Saruwatari, Sachiko ^a   Asoh, Hiroshi ^a   Sakurada, Tsugutomo ^a   Kuwata, Hiroshi ^c   Nakatani, Yoshihito ^c   Kudo, Ichiro ^c   Furukawa, Tatsuo ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c SHOWA UNIVERSITY   (Japan)

Author keywords

Cancer cells; LTB4; Phospholipase A2; PMN

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 5 HYDROXYICOSATETRAENOIC ACID; ARACHIDONIC ACID; CALCIMYCIN; CHEMOTACTIC FACTOR; LEUKOTRIENE B4; PHOSPHOLIPASE A2;

ADULT; ARTICLE; BREAST CANCER; CANCER CELL; CASE REPORT; CELL LYSATE; COLON CANCER; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; INFECTION COMPLICATION; LYMPH NODE METASTASIS; LYMPHOMA CELL; MALE; MONOCYTE; NEUTROPHIL; PERITONEAL FLUID; PLEURA EFFUSION; PRIORITY JOURNAL; STOMACH CANCER;

ASCITIC FLUID; CELL SEPARATION; COLONIC NEOPLASMS; HUMANS; LEUKOTRIENE B4; MALE; MIDDLE AGED; NEUTROPHILS; PHOSPHOLIPASES A; PLEURAL EFFUSION, MALIGNANT;

EID: 0031455935     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00347-9     Document Type: Article

References (21)

1. Pagani J.I., Libshitz H.I. Opportunistic fungal pneumonias in cancer patients. Am. J. Roentgenol. 137:1981;1033-1039.
2. Zier K., Gansbacher B., Salvadori S. Preventing abnormalities in signal transduction of T cells in cancer: the promise of cytokine gene therapy. Immunol. Today. 17:1996;39-45.
3. 2. J. Immunol. 143:1989;3222-3229.
4. Torisu M., Miyahara T., Yamamoto T., Harada M., Fujiwara H., Kitamura Y., Jimi M., Ohsato K., Tanaka J., Fukawa M. Fundamental and practical aspects of BCG immunotherapy in patients with the late stage of gastric cancer. Gann Monogr. 21:1978;173-179.
5. Ford-Hutchinson A.W., Bray M.A., Doig M.V., Shipley M.E., Smith M.J.H. Leukotriene B: a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 286:1980;264-265.
6. Uchida A., Micksche M. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432. J. Natl. Cancer Inst. 71:1983;673-680.
7. Kitsuki H., Katano M., Ikubo A., Morisaki T., Anann K., Tanaka M., Torisu M. Induction of inflammatory cytokines in effusion cavity by OK-432 injection therapy for patients with malignant effusion: role of interferon-γ in enhancement of surface expression of ICAM-1 on tumor cells in vivo. Clin. Immunol. Immunopathol. 78:1996;283-290.
8. 4 synthetase in mouse peritoneal exudate cells. Biochem. Biophys. Acta. 959:1988;386-398.
9. 4. Int. Arch. Allergy Immunol. 98:1992;361-369.
10. 2 and lysophosphatidylserine-specific lysophospholipase from rat platelets. J. Biochem. 101:1987;53-61.
11. Schimpff S.C., Scott D.A., Wade J.C. Infections in cancer patients: some controversial issues. Support. Care Cancer. 2:1994;94-104.
12. Ebert E.C., Roberts A.I., O'Connell S.M., Robertson F.M., Nagase H. Characterization of an immunosuppressive factor derived from colon cancer cells. J. Immunol. 138:1987;2161-2168.
13. Huber D., Philipp J., Fontana A. Protease inhibitors interfere with the transforming growth factor-β-dependent but not the transforming growth factor-β-independent pathway of tumor cell-mediated immunosuppression. J. Immunol. 148:1992;277-284.
14. Ferrone S., Marincola F.M. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol. Today. 16:1995;487-494.
15. Hahne M., Rimoldi D., Schroter M., Romero P., Schreier M., French L.E., Schneider P., Bornand T., Fontana A., Lienard D., Cerottini J.-C., Tschopp J. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science. 274:1996;1363-1366.
16. Spivak J.L. Cancer-related anemia: its causes and characteristics. Sem. Oncol. 21:1994;3-8.
17. 2. Am. J. Respir. Cell Mol. Biol. 15:1996;565-573.
18. Marcus A.J., Weksler B.B.B., Jaffe E.A., Broekman M.J. Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells. J. Clin. Invest. 66:1980;979-986.
19. 4. Proc. Natl. Acad. Sci. USA. 82:1985;6632-6636.
20. 4 by transcellular biosynthesis. Proc. Natl. Acad. Sci. USA. 83:1986;1349-1353.
21. 4 by human platelets. J. Biol. Chem. 263:1988;174-181.